Clinical Trial Update: A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating sitravatinib as monotherapy and in combination with tislelizumab in participants with unresectable locally advanced or met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Sitravatinib (sitravatinib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-18